Mariner Independent Advisor Network’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-32,473
Closed -$1.33M 465
2021
Q3
$1.33M Sell
32,473
-634
-2% -$34.7K 0.07% 289
2021
Q2
$1.88M Buy
33,107
+2,584
+8% +$95.4K 0.09% 246
2021
Q1
$1.28M Buy
30,523
+1,566
+5% +$89.2K 0.07% 271
2020
Q4
$2.03M Buy
+28,957
New +$1.19M 0.11% 195

Other funds holding EDIT

Mariner Independent Advisor Network's EDIT Position: Q4 2021 in Review

Mariner Independent Advisor Network sold out of Editas Medicine (EDIT) in Q4 2021, closing a stake of 32,473 shares — an estimated $1.33M sold.

Mariner Independent Advisor Network first reported a position in EDIT in Q4 2020 and held it in 4 quarters. The position peaked at $2.03M in Q4 2020. 305 funds tracked by Wall St. Rank hold EDIT as of Q4 2021.

  • Mariner Independent Advisor Network reported no remaining Editas Medicine position as of Q4 2021 after selling out during the quarter.
  • Mariner Independent Advisor Network sold 32,473 Editas Medicine shares in Q4 2021, an estimated $1.33M.
  • Mariner Independent Advisor Network first reported a position in Editas Medicine in Q4 2020 and held it in 4 quarters.
  • Mariner Independent Advisor Network's Editas Medicine position peaked at $2.03M in Q4 2020.
  • 305 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2021.

Based on Mariner Independent Advisor Network's 13F filing for Q4 2021, filed 16 Feb 2022.